Skip to main content
. 2021 Mar 22;15:655947. doi: 10.3389/fnhum.2021.655947

Table 3.

Effect of rTMS on fear extinction in clinical groups.

References Study type N/Groups Syndrome Gender, M/F (age, Mean ± SD) Target area Coil position Online/offline stimulation Pulses per session/duration Frequency/Intensity/Coil shape Outcome measures Outcome direction
Notzon et al. (2015) RCT, Single blind, active (control site) and sham controlled 83/4 Spider phobia 1) 4/37 (27.51 ± 9.4)
2) 5/37 (25.43 ± 7.37)
3) 4/36 (25.85 ± 7.65)
4) 5/38 (27.02 ± 9.23)
Left dlPFC F3 Offline, before the VR challenge iTBS/600/3 min 15 Hz/80% RMT/figure of 8 FSQ, SPQ, ASI, psychophysiological measures (HR, HRV, SCR) iTBS - had no general effect of on anxiety, disgust, HR and SCR. - significantly increased sympathetic activity
Herrmann et al. (2017) RCT, Double blind, sham controlled 39/2 Acrophobia 1) 6/13 (46.6 ± 13.7)
2) 7/13
13/26 (43.2 ± 12.6)
mPFC Fpz Offline, before exposure rTMS/1560/2 × 20 minutes 10 Hz/100% RMT/Round AQ, BAT - rTMS reduced phobic anxiety immediately after two sessions of VR exposure therapy. - No differences between active and sham rTMS stimulation at follow up.
Osuch et al. (2009) Double-blind, sham controlled 9/1 PTSD 1/8 (41.4 ± 12.3) Right dlPFC 5 cm rostral to APB muscle hotspot Online, during exposure to emotionally provoking memories. rTMS/1800/30 min per session/20 sessions 1 Hz/100% RMT/figure of 8 CAPS, IES, HDRS - Active rTMS showed a larger improvement of hyperarousal symptoms compared to sham
Isserles et al. (2013) RCT, Double-blind, sham controlled, controlled for traumatic event as well 26/3 PTSD 1) 7/2 (49 ± 12.5)
2) 8/1 (40.4 ± 10.5)
3) 5/3 (40.5 ± 9.8)
mPFC H-Coil designed tostimulate the mPFC. Offline, after exposure to the traumatic event Deep rTMS/1680/15.5 min per session/12 sessions 20 Hz/120% RMT/H-coil CAPS, PSS-SR, HDRS, BDI, psychophysiological data (HR) -Symptom improvement by dTMS (revealed by changes in CAPS, PSS-SR, HDRS, BDI and HR)
Fryml et al. (2019) RCT, Double blind, sham controlled 8/2 PTSD 1) 2/1 (30 ± 2.6)
2) 5/0 (27 ± 2.1)
Leftor right dlPFC 6 cm anterior to the right hand motor thumb area Online, duringprolonged exposure therapy rTMS/6000/30 min per session/8 sessions 10Hz/120% RMT/figure of 8 CAPS, HRSD - Change in HRSD showed antidepressant benefit of rTMS. - CAPS scores showed no significant improvement
Carmi et al. (2018) RCT, Double blind, sham controlled 41/3 OCD 1) 9/7 (36 ± 2.1)
2) 4/4 (28 ± 3.1)
3) 7/7 (35 ± 3.5)
mPFCand ACC 4 cm anterior to theleg motor spot at midline Offline, following symptom provocation Deep rTMS/HF: 2000 LF: 900/25 sessions HF: 20 Hz, LF: 1 Hz/HF: 100% RMT, LF: 110% RMT/H7 Coil YBOCS, CGI-I - Symptoms improved by high frequency deep rTMS (YBOCS, CGI-I)
Carmi et al. (2019) RCT, Double blind, sham controlled 94/2 OCD 1) 20/27; (41.1 ± 11.97)
2) 19/28 (36.5 ± 11.38)
mPFCand ACC 4 cm anterior to the foot motor spot Offline, following symptom provocation Deep rTMS/2,000/29 sessions 20 Hz/100% RMT/H7 coil YBOCS, CGI-I, CGI-S, and Sheehan Disability Scale scores - Symptom improvement by dTMS (YBOCS, CGI-I, CGI-S)
Adams et al. (2014) Case study, Single blind 1 OCD 1/0 (52 yo) Pre-supplementary motor area 50% of the distance between the Fz and FCz Offline, immediately prior ERP exercises rTMS/1200/20 min per session/15 sessions 1 Hz/110% RMT/figure of 8 YBOCS,PHQ-9,GAD-7, DOCS - Symptom improvement in YBOCS, DOCS, GAD-7, and PHQ-9
Grassi et al. (2015) Case study 1 OCD 0/1 (32 yo) Left dlPFC N.R. Offline, immediately prior ERP exercises. rTMS/1800/N.A./10 sessions 10 Hz/80% RMT/NR Y-BOCS, CGI-I, HAM-D, GAF - Symptom improvement in Y-BOCS, CGI-I, GAF

ACC, Anterior cingulate cortex; dlPFC, dorsolateral prefrontal cortex; mPFC, medial prefrontal cortex; vmPFC, ventromedial prefrontal cortex; iTBS, intermittent theta burst stimulation; rTMS, repetitive transcranial magnetic stimulation; LF, low frequency; HF, high frequency; MEP, motor evoked potential; RMT, resting motor threshold; PTSD, Posttraumatic stress disorder; OCD, Obsessive-Compulsive disorder; HR, heart rate; HRV, heart rate variability; SCR, Skin conductance response; EEG, electroencephalography; FPS, Fear potentiated startle; fNIRS, Functional near-infrared spectroscopy; CAPS, Clinician Administered PTSD Scale; IES, The Impact of Event Scale; SPQ, Spider Phobia Questionnaire; FSQ, Fear of Spiders Questionnaire; ASI, Anxiety Sensitivity Index; AQ, acrophobia questionnaire; BAT, Behavioral Avoidance Test; BDI, Beck Depression Inventory; HDS, Hamilton Depression scale; HDRS, Hamilton Rating Scale for Depression; PGI-T, Patient Global Impression of Improvement; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale; GAF, Global Assessment of Functioning; GAD-7, General Anxiety Disorder Scale; PHQ-9, Patient Health Questionnaire; DOCS, Dimensional Obsessive-Compulsive Scale; CGI-S, Clinical Global Impression—severity scale; CGI-I, The CGI—improvement scale; ERP, Exposure Response Prevention; N/A, not applicable; N.R., not reported.